LAG3 and neoplasm: Furthermore, we noted that the proportion of effector memory CD8+ and CD4+ T cells in the spleens and lymph nodes of mice that successfully eradicated an MSH2 KO tumor following anti-PD-1 and anti-LAG3 therapy was higher compared to mice unable to eliminate the tumor (Extended Figure 15 J).